Shares of Varian (VARI) have recently tested investors patience. (Editor's note: this stock is not to be confused with Varian Medical Systems or Varian Semiconductor.). The company's stock has fallen 10+% since the company reported better than expected fiscal second quarter (ended March) results. The stock is down 37% lower from its October highs.Varian makes scientific instruments such as spectroscopy systems and high-vacuum pumps that are used in chemical analysis, biomedicine and materials research. Some of Varian's larger customers include Dow Chemical (DOW - Get Report), Monsanto (MON - Get Report), Pfizer (PFE - Get Report) and Procter & Gamble (PG - Get Report).
Should You Buy It: Varian's a Buy
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.